psychiatry
Brief Addiction Monitor (BAM)
17-item instrument for monitoring patients in addiction treatment. Assesses substance use, protective factors, and risk factors for relapse. Designed for routine use at each treatment visit.
References
- Cacciola JS et al. Development and initial evaluation of the Brief Addiction Monitor (BAM). J Subst Abuse Treat. 2013;44(3):256–263.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Thiamine (IV/IM — Pabrinex) · Vitamin B1 (Thiamine) — deficiency treatment / Wernicke's encephalopathy prevention
- Dextrose 10% IV · IV glucose solution (hypoglycaemia treatment)
- Glucose · Carbohydrate / hypoglycaemia treatment
- Medroxyprogesterone Acetate (DMPA) · Injectable Progestogen Contraceptive / Hormone Treatment
- Demeclocycline hydrochloride · Tetracycline antibiotic / off-label SIADH treatment
- Prednisolone (Sudden Sensorineural Hearing Loss) · Corticosteroid (systemic — SSNHL treatment)
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.